SMTL ID : 4g2f.1

Human EphA3 kinase domain in complex with compound 7

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x C07: 1-amino-5-(5-hydroxy-2-methylphenyl)-7,8,9,10-tetrahydropyrimido[4,5-c]isoquinolin-6(5H)-one(Non-covalent)

C07.1: 11 residues within 4Å: Chain A: A.65, K.67, E.84, M.88, T.113, E.114, Y.115, M.116, L.167, S.177, D.178 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:A.65, A:K.67, A:K.67, A:T.113, A:L.167 Hydrogen bonds: A:M.116, A:M.116, A:S.177, A:D.178 Water bridges: A:K.67, A:K.67, A:S.177 pi-Cation interactions: A:K.67

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhao, H. et al., Discovery of a novel chemotype of tyrosine kinase inhibitors by fragment-based docking and molecular dynamics. ACS MED.CHEM.LETT. (2012)

Release Date

2012-10-24

Peptides

EPH receptor A3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

EPH receptor A3

Related Entries With Identical Sequence